ArtVentive Medical Group, Inc. is an innovative medical device company focused on developing, manufacturing, and marketing a family of endoluminal occlusion devices (ArtVentive EOS™), enabling a minimally invasive, immediate occlusion of targeted veins and arteries within the body.

ArtVentive received its CE European Union approval for its ArtVentive EOS™ Plug in 2013, and recently received FDA clearance, paving the way for the expansion of ArtVentive’s manufacturing, marketing, and sales of the ArtVentive EOS™ Plug globally. ArtVentive is committed to capitalizing on the significant opportunities within the global health care industry.

For more information regarding investor relations, please email: or fax: 650-240-1706.